Finance

Lists
002390:SHE
Guizhou Xinbang Pharmaceutical Co Ltd
2,85 CN¥
0,00%
(0,00) 1D
16-окт., 15:04:36 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002390...
Open
2,86 CN¥
High
2,93 CN¥
Low
2,82 CN¥
Mkt. cap
5,70 млд
Avg. vol.
25,64 млн
Volume
26,97 млн
Dividend
3,16%
Quarterly dividend
0,02 CN¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
47,77
52-wk high
4,15 CN¥
52-wk low
2,54 CN¥
EPS
0,06 CN¥
Shares outstanding
1,94 млд
No. of employees
5 миң
Open
2,86 CN¥
High
2,93 CN¥
Low
2,82 CN¥
Mkt. cap
5,70 млд
Avg. vol.
25,64 млн
Volume
26,97 млн
Dividend
3,16%
Quarterly dividend
0,02 CN¥
Ex-dividend date
2026-ж., 29-сен.
P/E ratio
47,77
52-wk high
4,15 CN¥
52-wk low
2,54 CN¥
EPS
0,06 CN¥
Shares outstanding
1,94 млд
No. of employees
5 миң
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
10 мүнөт мурун
Phase 3 Lung Trials Could Be A Big Test For Insmed (INSM)
Yahoo Finance
Yahoo Finance
·
45 мүнөт мурун
Dow (DOW) Stock Could Look Reasonable After a 43% Gain
Seeking Alpha
Seeking Alpha
·
1 саат мурун
S&P 500 Snapshot: Stocks Slide Nearly 2% For The Week
About Guizhou Xinbang Pharmaceutical Co Ltd
CEO-
Employees4,7 миң
Founded1995-ж., 27-янв.
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,42 млд
1,35 млд
1,26 млд
1,20 млд
Cost of goods sold
1,17 млд
1,12 млд
1,06 млд
1,01 млд
Cost of revenue
1,17 млд
1,12 млд
1,06 млд
1,01 млд
Research and development expenses
1,28 млн
1,50 млн
1,95 млн
2,40 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
151,56 млн
153,22 млн
121,62 млн
114,72 млн
Operating expense
175,60 млн
181,58 млн
127,31 млн
129,01 млн
Total operating expenses
1,34 млд
1,30 млд
1,19 млд
1,14 млд
Operating income
76,59 млн
54,46 млн
77,38 млн
65,80 млн
Other non operating income
-6,48 млн
-56,24 млн
259,61 миң
-5,96 млн
EBT including unusual items
65,97 млн
4,74 млн
76,27 млн
77,46 млн
EBT excluding unusual items
65,91 млн
16,58 млн
76,18 млн
74,99 млн
Income tax expense
7,64 млн
13,72 млн
11,71 млн
5,89 млн
Effective tax rate
11,57%
289,59%
15,36%
7,61%
Other operating expenses
17,06 млн
10,40 млн
5,92 млн
7,90 млн
Net income
45,13 млн
-32,04 млн
48,66 млн
50,93 млн
Net profit margin
3,18%
-2,37%
3,85%
4,23%
Earnings per share
-
-
-
-
Interest and investment income
1,56 млн
20,59 млн
1,86 млн
18,18 млн
Interest expense
-5,76 млн
-2,25 млн
-3,32 млн
-3,02 млн
Net interest expenses
-4,20 млн
18,35 млн
-1,45 млн
15,16 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
128,65 млн
102,75 млн
125,66 млн
112,94 млн
Gain or loss from assets sale
95,70 миң
3,48 млн
-
524,45 миң
AI content may include mistakes. Learn more
Google колдонмолору